LEVIN MARK J - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for LEVIN MARK J
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-11-12
Sale
2021-11-16
7:57 pm
Jounce Therapeutics Inc.JNCEThird Rock Ventures III L.P.
Third Rock Ventures GP III L.P.
TRV GP III LLC
STARR KEVIN P
TEPPER ROBERT I
LEVIN MARK J
10% Owner
1,900,000$8.38$15,922,0004,698,661
(Indirect
Direct)
View
2021-06-03
Sale
2021-06-07
6:10 pm
Revolution Medicines Inc.RVMDThird Rock Ventures II L.P.
Third Rock Ventures GP II L.P.
TRV GP II LLC
STARR KEVIN P
TEPPER ROBERT I
LEVIN MARK J
10% Owner
543,113$30.21$16,406,9625,911,804
(Indirect
Direct)
View
2021-05-25
Sale
2021-05-27
5:43 pm
Revolution Medicines Inc.RVMDThird Rock Ventures II L.P.
Third Rock Ventures GP II L.P.
TRV GP II LLC
STARR KEVIN P
TEPPER ROBERT I
LEVIN MARK J
10% Owner
1,366,204$30.57$41,764,2086,454,917
(Indirect
Direct)
View
2021-05-25
Sale
2021-05-27
5:42 pm
Jounce Therapeutics Inc.JNCEThird Rock Ventures II L.P.
Third Rock Ventures GP II L.P.
TRV GP II LLC
STARR KEVIN P
TEPPER ROBERT I
LEVIN MARK J
10% Owner
552,520$8$4,420,1609,387,176
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-11-10
Other
2021-11-12
5:31 pm
N/A
N/A
Fulcrum Therapeutics Inc.FULCLEVIN MARK J
Director
10% Owner
1,000,000$05,046,425
(Indirect)
View
2021-09-22
Other
2021-09-24
4:13 pm
N/A
N/A
Fulcrum Therapeutics Inc.FULCLEVIN MARK J
Director
10% Owner
1,000,000$06,004,051
(Indirect)
View
2021-09-15
Other
2021-09-17
4:15 pm
N/A
N/A
Jounce Therapeutics Inc.JNCEThird Rock Ventures II L.P.
Third Rock Ventures GP II L.P.
TRV GP II LLC
STARR KEVIN P
TEPPER ROBERT I
LEVIN MARK J
10% Owner
1,750,000$08,348,661
(Direct)
View
2021-06-10
Other
2021-06-14
4:19 pm
N/A
N/A
Jounce Therapeutics Inc.JNCEThird Rock Ventures II L.P.
Third Rock Ventures GP II L.P.
TRV GP II LLC
STARR KEVIN P
TEPPER ROBERT I
LEVIN MARK J
10% Owner
1,500,000$09,647,049
(Direct)
View
2021-06-09
Option Award
2021-06-11
5:11 pm
N/A
2031-06-08
Fulcrum Therapeutics Inc.FULCLEVIN MARK J
Director
15,000$015,000
(Direct)
View
2021-06-03
Option Award
2021-06-04
4:32 pm
N/A
2031-06-03
Voyager Therapeutics Inc.VYGRLEVIN MARK J
Director
10% Owner
15,000$015,000
(Direct)
View
2021-05-06
Other
2021-05-10
4:41 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXThird Rock Ventures III L.P.
Third Rock Ventures GP III L.P.
TRV GP III LLC
STARR KEVIN P
TEPPER ROBERT I
LEVIN MARK J
10% Owner
1,085,784$04,768,725
(Direct)
View
2021-03-11
Other
2021-03-15
4:15 pm
N/A
N/A
Jounce Therapeutics Inc.JNCEThird Rock Ventures II L.P.
Third Rock Ventures GP II L.P.
TRV GP II LLC
STARR KEVIN P
TEPPER ROBERT I
LEVIN MARK J
10% Owner
1,250,000$011,189,696
(Direct)
View